Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Ophthalmology

Standard Treatments: Rebuilding the Drainage System

At a Glance

For adults with symptomatic, completely blocked acquired tear ducts, dacryocystorhinostomy, or DCR, is usually the standard treatment. It creates a new drainage opening between the tear sac and nose; external and endoscopic approaches are both effective.

When chronic inflammation and scar tissue have completely blocked your tear duct, the most effective solution is often to create a brand-new drainage pathway. This definitive surgical treatment is known as a Dacryocystorhinostomy (DCR).

Because the original duct is too scarred to simply “unclog,” a DCR bypasses the blockage entirely by creating a new opening between the tear sac and the inside of your nose [1][2]. This is considered the standard of care for treating symptomatic, complete acquired tear duct obstruction in adults.

Comparing Your Surgical Options

There are two primary ways to perform a DCR. Both are highly effective, with functional success rates typically ranging around 88% to 92%, though exact outcomes depend on your specific anatomy, whether success means an open ostium or symptom relief, and how long you are followed [1][3].

External DCR

In this traditional approach, the surgeon makes a small incision (about 10–15 mm) on the side of your nose where your glasses might sit [4].

  • Pros: It allows the surgeon the best direct view of the anatomy and has been the standard of care for decades [5].
  • Cons: It leaves a small visible scar, though this typically fades significantly over time [4].

Endoscopic DCR

This approach is performed entirely through the nostrils using a tiny camera (endoscope) and specialized tools. There is no skin incision [1].

  • Pros: There is no external scar, and recovery is often slightly faster [4][6].
  • Cons: It can be more technically challenging for the surgeon if your nasal passages are very narrow, and some studies suggest a slightly higher risk of minor intraoperative hemorrhage [6].

The Debate Over Silicone Stents

During a DCR, your surgeon may place a thin, flexible silicone stent (a tiny tube) through the new opening to keep it from closing as it heals [7]. Whether or not to use a stent is a topic of ongoing debate among specialists:

  • Potential Benefits: Some meta-analyses suggest that stenting may slightly improve anatomical success (ensuring the hole stays open). It is often utilized for patients with canalicular disease, trauma, or revision surgery [7][8].
  • Potential Downsides: Stents can sometimes cause tube displacement, punctal or nasal irritation, infection, or the growth of granulation tissue (extra scar-like tissue) that can actually block the duct further [7].
  • Long-Term Results: Many randomized trials have found no significant difference in long-term tearing symptoms between patients who had a stent and those who did not [9][10].

Your surgeon will decide whether a stent is right for you based on the size of your tear sac and specific clinical findings [11][2].

What to Expect: Surgical Risks and Recovery

DCR is generally a very safe outpatient surgery, performed under either local or general anesthesia. However, as with any surgery, you should be aware of the risks:

  • Common: Bruising around the eye, expected nasal bleeding for the first few days, and temporary nasal congestion.
  • Potential Risks: Infection, displacement of the stent, or restenosis (recurrence of the blockage, which may require a revision surgery).
  • Rare Risks: Severe bleeding, anesthesia risks, or injury to surrounding orbital structures.

Why Less Invasive Options Are Selected Carefully

Procedures like probing or balloon dacryoplasty (inflating a tiny balloon to stretch the duct) are highly effective in babies, but have notably lower success rates for adults with complete blockages [1]. However, they may still be considered for selected partial obstructions, canalicular disease, or particular anatomy [12].

Factors That Can Affect Your Outcome

While DCR is highly successful, certain factors can make the surgery more complex or increase the risk of the blockage returning:

  • Canalicular Disease: If the very small tubes that lead into the tear sac are also blocked, a standard DCR may not be enough to stop the tearing [13][14].
  • Small Lacrimal Sac: A very small or shrunken tear sac can make it harder to create a durable new drainage hole [11][14].
  • History of Infection: Patients who have had severe infections of the tear sac (dacryocystitis) or who have blockages in both eyes may have a slightly higher risk of recurrence [15].
  • Secondary Causes: If your blockage was caused by radiation therapy or radioactive iodine (SANDO), the success rates may be slightly lower due to more extensive tissue scarring [16].

Common questions in this guide

What surgery is usually used for a completely blocked tear duct in an adult?
Dacryocystorhinostomy, or DCR, is usually the standard treatment for a symptomatic complete acquired tear duct blockage in adults. It bypasses the scarred duct by creating a new opening between the tear sac and the inside of the nose.
Is external or endoscopic DCR better for tear duct blockage?
Both approaches are highly effective, with typical functional success rates of about 88% to 92%. External DCR provides a direct view but leaves a small scar, while endoscopic DCR is performed through the nose without a skin incision; the best option depends on your anatomy and surgeon's assessment.
Will I need a silicone stent during DCR surgery?
A surgeon may place a thin silicone tube to help keep the new drainage opening open while it heals. Stents may be especially useful with canalicular disease, trauma, or revision surgery, but they can cause irritation, displacement, infection, or extra scar-like tissue, so the decision is individualized.
What should I expect while recovering from DCR surgery?
DCR is generally an outpatient procedure performed with local or general anesthesia. Bruising around the eye, a small amount of nasal bleeding for several days, and temporary congestion are common, while infection, stent displacement, and recurrent blockage are possible complications.
What happens if my eye still waters after DCR?
Persistent tearing may require evaluation for recurrent blockage, canalicular disease, a small lacrimal sac, or another drainage problem. Depending on the cause, your surgeon may recommend additional testing, treatment, or revision surgery.
Can probing or balloon treatment fix an acquired blocked tear duct?
Probing and balloon dacryoplasty are less reliable for adults with complete tear duct blockage than they are for babies. They may still be considered in selected adults with a partial obstruction, canalicular disease, or anatomy that makes another approach appropriate.

Get notified when new evidence is published on acquired tear duct stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Best treatments available for distal acquired lacrimal obstruction: A systematic review and meta-analysis.

    Vinciguerra A, Nonis A, Giordano Resti A, et al.

    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2020; (45(4)):545-557 doi:10.1111/coa.13551.

    PMID: 32304619
  2. 2

    Endoscopic dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction: A systematic review and pooled analysis of powered vs. non-powered technique.

    Daloiso A, Gaudioso P, Negrisolo M, et al.

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2026; (283(5)):2827-2847 doi:10.1007/s00405-025-09961-1.

    PMID: 41786947
  3. 3

    Trends and Outcomes of Endoscopic Versus External Dacryocystorhinostomy: A 20-year Retrospective Multi-Institutional Analysis.

    Davila N, McLaughlin SA, Pradeep T, et al.

    Ophthalmic plastic and reconstructive surgery 2026; (42(2)):196-201 doi:10.1097/IOP.0000000000003049.

    PMID: 40865166
  4. 4

    Clinical Trial to Compare Success Rate of Endonasal Dacryocystorhinostomy and External Dacryocystorhinostomy for Treatment of Primary Acquired Nasolacrimal Duct Obstruction.

    Khatri MS, Kharaya A

    Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2022; (74(Suppl 2)):1266-1273 doi:10.1007/s12070-020-02352-4.

    PMID: 36452658
  5. 5

    Modified External Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.

    Sharma HR, Sharma AK, Sharma R

    Journal of clinical and diagnostic research : JCDR 2015; (9(10)):NC01-5 doi:10.7860/JCDR/2015/15940.6624.

    PMID: 26557549
  6. 6

    External versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction.

    Rajabi MT, Shahraki K, Nozare A, et al.

    Middle East African journal of ophthalmology 2022; (29(1)):1-6 doi:10.4103/meajo.meajo_238_21.

    PMID: 36685339
  7. 7

    Safety and efficacy of silicone intubation compared to standard techniques in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis.

    Dar A, Jalal AA, Ibrahim M, et al.

    International ophthalmology 2026; (46(1)).

    PMID: 42455412
  8. 8

    Meta-analysis of randomized controlled trials in dacryocystorhinostomy with and without silicone intubation.

    Ing EB, Bedi H, Hussain A, et al.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2018; (53(5)):466-470 doi:10.1016/j.jcjo.2017.12.006.

    PMID: 30340712
  9. 9

    Prospective, randomised clinical trial on the necessity of using a silicone intubarium in the context of endonasal-endoscopic dacryocystorhinostomy (EN-DCR) in patients with postsaccal lacrimal duct stenosis.

    Bahner L, Zebralla V, Dietz A, et al.

    International ophthalmology 2024; (44(1)):293 doi:10.1007/s10792-024-03205-7.

    PMID: 38940962
  10. 10

    Randomized Controlled Trial on Silicone Intubation in Endoscopic Mechanical Dacryocystorhinostomy (SEND): An 11-year Outcome Report.

    Chan KK, Yung GW, Chee ASH, et al.

    Seminars in ophthalmology 2025; (40(1)):54-60 doi:10.1080/08820538.2024.2385391.

    PMID: 39246013
  11. 11

    Predictors of nasolacrimal duct intubation failure for primary acquired nasolacrimal duct obstruction: a computed tomography-dacryocystography (CT-DCG) study.

    Wang W, Lin T, Gong L, Wang Y

    Quantitative imaging in medicine and surgery 2024; (14(10)):7229-7236 doi:10.21037/qims-24-519.

    PMID: 39429569
  12. 12

    [Minimally invasive therapy for nasolacrimal duct obstructions].

    Emmerich KH, Lang M, Meyer-Rüsenberg H

    Klinische Monatsblatter fur Augenheilkunde 2024; (241(12)):1361-1371 doi:10.1055/a-2375-0128.

    PMID: 39255814
  13. 13

    Endoscopic dacryocystorhinostomy as treatment for lower lacrimal pathway obstructions in adults: Review article.

    Penttilä E, Smirnov G, Tuomilehto H, et al.

    Allergy & rhinology (Providence, R.I.) 2015; (6(1)):12-9 doi:10.2500/ar.2015.6.0116.

    PMID: 25860166
  14. 14

    Surgical outcomes of external dacryocystorhinostomy and risk factors for functional failure: a 10-year experience.

    Lee MJ, Khwarg SI, Kim IH, et al.

    Eye (London, England) 2017; (31(5)):691-697 doi:10.1038/eye.2016.308.

    PMID: 28085144
  15. 15

    Role of paranasal abnormalities and systemic inflammation on primary acquired nasolacrimal duct obstruction.

    Sevimli N, Aydın Kurna S, Çakır M, Akkaya S

    Journal of ophthalmic inflammation and infection 2024; (14(1)):38 doi:10.1186/s12348-024-00416-y.

    PMID: 39143354
  16. 16

    Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.

    Sweeney AR, Davis GE, Chang SH, Amadi AJ

    Ophthalmic plastic and reconstructive surgery 2018; (34(1)):20-25 doi:10.1097/IOP.0000000000000841.

    PMID: 27997463

This page is for educational purposes only and does not constitute medical advice. Your ophthalmic surgeon should recommend the DCR approach and stent plan based on your anatomy, symptoms, and medical history.